These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16772076)

  • 1. [The effects of different clinicopathologic variables on serum protein fingerprint in hepatocellular carcinoma patients].
    Huang C; Fan J; Zhou J; Liu YK; Cui JF
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):445-9. PubMed ID: 16772076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of serum proteome biomarkers with relation to the formation of portal vein tumor thrombi in hepatocellular carcinoma patients].
    Huang C; Fan J; Zhou J; Liu YK; Cui JF; Kang XN; Yang PY; Tang ZY
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):781-5. PubMed ID: 15949388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
    Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening low molecular weight protein biomarkers relevant to portal vein tumor thrombi in serum of patients with hepatocellular carcinoma].
    Qiu JG; Fan J; Liu YK; Zhou J; Qiu SJ; Dai Z; Kang XN; Huang C; Yang PY; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jul; 15(7):498-502. PubMed ID: 17669237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases.
    Paradis V; Degos F; Dargère D; Pham N; Belghiti J; Degott C; Janeau JL; Bezeaud A; Delforge D; Cubizolles M; Laurendeau I; Bedossa P
    Hepatology; 2005 Jan; 41(1):40-7. PubMed ID: 15690480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of portal vein microscopic and macroscopic tumor thrombi on post-operation patients with hepatocellular carcinoma].
    Fan J; Tang ZY; Wu ZQ; Zhou J; Zhou XD; Ma ZC; Qin LX; Qiu SJ; Yu Y; Huang C
    Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):433-5. PubMed ID: 15854367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I.
    Xu X; Wei X; Ling Q; Cheng J; Zhou B; Xie H; Zhou L; Zheng S
    J Gastroenterol Hepatol; 2011 Dec; 26(12):1787-94. PubMed ID: 21649721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma.
    Chen XP; Qiu FZ; Wu ZD; Zhang ZW; Huang ZY; Chen YF; Zhang BX; He SQ; Zhang WG
    Ann Surg Oncol; 2006 Jul; 13(7):940-6. PubMed ID: 16788755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Percutaneous laser ablation in the treatment of portal vein tumor thrombus in 93 hepatocellular carcinoma patients].
    Lu ZH; Shen F; Yuan GX; Shi LH; Zong M; Yang JH; Guo J; Wu MC
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):449-52. PubMed ID: 17974281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
    Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma].
    Hou YK; Wang Y; Cong WM; Wu MC
    Ai Zheng; 2007 Jun; 26(6):591-5. PubMed ID: 17562263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors of hepatocellular carcinoma after liver transplantation].
    Zhou LX; Yan LN
    Ai Zheng; 2006 Jun; 25(6):736-9. PubMed ID: 16764771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion.
    Aldrighetti L; Pulitanò C; Catena M; Arru M; Guzzetti E; Halliday J; Ferla G
    Ann Surg Oncol; 2009 May; 16(5):1254. PubMed ID: 19277788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
    Peng ZW; Guo RP; Zhang YJ; Lin XJ; Chen MS; Lau WY
    Cancer; 2012 Oct; 118(19):4725-36. PubMed ID: 22359112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
    Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.